Location

Please check the individual session for location or broadcast availability.  

Frequency

Semi-monthly

Series Director

Sravanti P. Teegavarapu, MD

Series Co-Director

Tareq Abuasab, MD

Target Audience

Needs Statement

The Hematological Multidisciplinary Tumor Board addresses key educational needs by fostering real-time, collaborative learning that enhances provider competence in managing hematologic malignancies. Through case-based discussions involving radiology, pathology, and clinical specialties, participants gain exposure to evolving diagnostic tools, treatment guidelines, and therapeutic innovations. This series promotes the integration of evidence-based literature and clinical trial data into decision-making, helping clinicians apply the latest standards of care to complex cases. It also supports performance improvement by facilitating changes in diagnosis, testing, and treatment planning, especially in challenging or atypical presentations. As a continuous learning platform, the series engages diverse healthcare professionals and promotes interdisciplinary education and quality improvement across care settings.

Educational Methods

Educational methods will include case presentations.

Objectives

At the conclusion of the sessions, the participants should be able to:

• Describe the latest evidence-based treatments for hematologic malignancies.
• Select appropriate imaging, laboratory, and molecular studies to support the diagnosis and staging of complex hematologic malignancies in a multidisciplinary setting.
• Apply evidence-based guidelines and institutional protocols to develop individualized, multi-modal treatment plans for patients with hematologic malignancies, incorporating input from pathology, radiology, and clinical specialties.
• Evaluate opportunities for clinical trial enrollment and timely referral based on patient eligibility, disease stage, and treatment response, aiming to optimize outcomes and expand access to novel therapies.

Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator